Fucosylated glycans, Lewis Y (Ley), can enhance the capacity of CD47-SIRP signaling and then enables the tumor cell to evade the phagocytosis or programmed cell clearance [26, 27]. The gene discussed is SIRPA; the disease is neoplasm.